MSK radiation oncologist Paul Romesser

Paul Romesser, MD

Radiation Oncologist

Clinical Expertise

Gastrointestinal Cancers; Rectal Cancer; Anal Cancer; Image-guided radiation therapy (IGRT); Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Radiosurgery (SRS), Proton Beam Radiotherapy (PBRT)

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Romesser accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me

Education

MD, Boston University School of Medicine

Residencies

Radiation Oncology - Memorial Sloan Kettering Cancer Center

I am a board-certified radiation oncologist who has expertise in using advanced techniques to treat cancer. These include image-guided radiation therapy, intensity-modulated radiation therapy, stereotactic radiosurgery, and proton beam radiotherapy. I am also actively involved in cancer clinical trials. I work to take ideas developed in the lab and translate them into actual trials and treatments that can benefit people with cancer. I am a member of the NRG Oncology colorectal and non-colorectal gastrointestinal cancer committees and the National Cancer Institute’s Rectal-Anal Task Force. My work has been published in Nature, Science, Lancet Oncology, Clinical Cancer Research, International Journal of Radiation Oncology and Biophysics, and Cancer.

At Memorial Sloan Kettering, we approach treating cancer as a team. I work closely with surgical and medical oncologists, radiologists, and pathologists. I can confidently tell my patients that they will receive the best care in the world because of the team of experts that will support them every step of the way. I make sure all my patients are aware of who is on their care team, our individual roles, and how we work together to create a personalized treatment plan.

I also make sure my patients have a solid understanding of their diagnosis. I take time to explain how radiation therapy fits into treating their disease, as well as all the potential benefits and side effects. While many patients have concerns about radiation therapy, I hope that after meeting with me, they and their families feel reassured about what lies ahead. 

Clinical trials, in my opinion, offer patients an opportunity to get the most progressive cancer care available. I know that the decision to participate or not participate in a trial can make people anxious. Ultimately the decision is a very personal one for patients and their families. I hope that by explaining the ins and outs of clinical trials, I can help guide my patients to make the right decision for them.

After patients leave my office, I hope that they feel that they have a strong advocate who will stop at nothing to ensure they are getting the best treatment. 

I can confidently tell my patients that they will receive the best care in the world because of the team of experts that will support them every step of the way.

Dr. Romesser

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

Clinical Trials

Smiling doctors in the lab

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Research and Publications

Romesser PB, Cahlon O, Scher E, Zhou Y, Berry SL, Rybkin A, Sine KM, Tang S, Sherman EJ, Wong R, Lee NY. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. Radiotherapy and Oncology. 2016; 118(2):286-292. PMID 26867969.

Romesser PB, Cahlon O, Scher ED, Hug EB, Sine K, DeSelm C, Fox, JL, Mah D, Garg, MK, Chang J, Lee NY. Proton beam re-irradiation for recurrent head and neck cancer: multi-institutional report on feasibility and early outcomes. International Journal of Radiation Oncology Biology, and Physics. 2016; 95(1):386-395. PMID: 27084656.

Romesser PB, Romanyshyn JC, Schupak KD, Setton J, Riaz N, Wolden SL, Gelblum DY, Sherman EJ, Kraus D, Lee NY. Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity-modulated radiotherapy with concurrent chemotherapy.  Cancer. 2012; 118(24):6072-6078. PMID 22707358.

Romesser PB, Sherman EJ, Shaha AR, Lian M, Wong RJ, Sabra M, Rao SS, Fagin JA, Tuttle RM, Lee NY. External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancer. Journal of Surgical Oncology. 2014; 110(4):375-382. PMID 24961938.

Romesser PB, Lim R, Spratt DE, Setton J, Riaz N, Lok B, Sherman EJ, Schoder H, Lee NY. The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pretreatment 18F-fluorodeoxyglucose positron emission tomography scan. Oral Oncology. 2014; 50(9):802-808. PMID 25043882.

Publications on PubMed

Visit PubMed for a full listing of Dr. Romesser’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.